These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24225156)

  • 21. [New drugs in the therapy of colorectal cancer].
    Bajetta E; Cassata A; Cortinovis D
    Tumori; 2001; 87(1 Suppl 1):S3-4. PubMed ID: 11300017
    [No Abstract]   [Full Text] [Related]  

  • 22. Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials.
    Kerbel RS; Grothey A
    Nat Rev Clin Oncol; 2015 Jun; 12(6):313-4. PubMed ID: 25963090
    [No Abstract]   [Full Text] [Related]  

  • 23. [Does an effective adjuvant treatment in colorectal cancer exist?].
    Díaz-Rubio E
    Rev Clin Esp; 1993 Feb; 192(2):59-61. PubMed ID: 8460235
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors dictating outcomes in patients with colorectal cancer and peritoneal carcinomatosis: selection, resection, or convection?
    Cercek A; Saltz L
    J Clin Oncol; 2012 Jan; 30(3):226-8. PubMed ID: 22162591
    [No Abstract]   [Full Text] [Related]  

  • 25. [First-line chemotherapy for unresectable and metastatic colorectal cancer].
    Satoh T
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1372-5. PubMed ID: 25577805
    [No Abstract]   [Full Text] [Related]  

  • 26. HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?
    Hochster HS
    Br J Cancer; 2013 Feb; 108(3):477-8. PubMed ID: 23422787
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent advances in colorectal chemotherapy: oral fluorinated pyrimidines, oxaliplatin and irinotecan.
    Pazdur R
    J Gastroenterol; 2000; 35 Suppl 12():131. PubMed ID: 10779234
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy improves prognosis in colorectal carcinoma. Soon oral therapy at home?].
    MMW Fortschr Med; 2002 Nov; 144(46):71. PubMed ID: 12534092
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness and Cost Effectiveness of Bevacizumab in Metastatic Colorectal Cancer.
    Messori A; De Rosa M; Fadda V; Pani L
    J Clin Oncol; 2015 Nov; 33(32):3838-9. PubMed ID: 26304897
    [No Abstract]   [Full Text] [Related]  

  • 30. Second-line option for colorectal cancer.
    Cancer Discov; 2015 Mar; 5(3):OF3. PubMed ID: 25616856
    [No Abstract]   [Full Text] [Related]  

  • 31. Current treatment benefits in advanced colorectal cancer.
    Scheithauer W
    Lancet Oncol; 2007 Oct; 8(10):857-9. PubMed ID: 17913652
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adjuvant and palliative therapy for colorectal carcinoma].
    Heike M; Wölfel T; Meyer zum Büschenfelde KH; Knuth A; Dippold WG
    Dtsch Med Wochenschr; 1994 May; 119(21):778-85. PubMed ID: 7514969
    [No Abstract]   [Full Text] [Related]  

  • 33. FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
    Matsuoka A; Maeda O; Ando Y
    N Engl J Med; 2015 Jan; 372(3):291. PubMed ID: 25587962
    [No Abstract]   [Full Text] [Related]  

  • 34. FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
    Haines IE
    N Engl J Med; 2015 Jan; 372(3):290-1. PubMed ID: 25587961
    [No Abstract]   [Full Text] [Related]  

  • 35. FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
    Cremolini C; Loupakis F; Falcone A
    N Engl J Med; 2015 Jan; 372(3):291-2. PubMed ID: 25587960
    [No Abstract]   [Full Text] [Related]  

  • 36. [Progress of chemotherapy in colorectal cancer].
    Komatsu Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1771-6. PubMed ID: 18064761
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastrointestinal cancer: FOLFOXIRI-improving outcomes of metastatic colorectal cancer.
    Errico A
    Nat Rev Clin Oncol; 2014 Dec; 11(12):684. PubMed ID: 25384949
    [No Abstract]   [Full Text] [Related]  

  • 38. Cetuximab in the treatment of colorectal cancer.
    Goldberg RM; Venook AP; Schilsky RL
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):1-10; quiz 11-12. PubMed ID: 16170891
    [No Abstract]   [Full Text] [Related]  

  • 39. Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard?
    Schmoll HJ; Sargent D
    Lancet; 2007 Jul; 370(9582):105-107. PubMed ID: 17630019
    [No Abstract]   [Full Text] [Related]  

  • 40. Integration of targeted therapies with cytotoxic chemotherapy in the treatment of colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S6. PubMed ID: 20630852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.